2006, Number 2
Comparative effectiveness between 0.1% metilprednisolone aceponate and 0.5% betamethasone dipropionate among children whit nonretractable prepuce.
PDF size: 431.62 Kb.
ABSTRACTObjective: To compare clinical improvement between treatment with metilprednisolone aceponate vs. betamethasone dipropionate among children with nonretractable prepuce.
Material and methods: Between August 2001 and November 2002, we carried out a double blind and controlled clinical trial in 34 children with a diagnosis of nonretracable prepuce. Children were randomly assigned to one of the following groups and topical treatment was administered: Group A; metilprednisolone aceponate 0.1% and Group B; betamethasone dipropionate 0.05%.
Results:2 = 0.2; p = 0.6).
Conclusions: The percentage of clinical improvement was similar between the two groups of topical steroid treatment administered.
Harrison RM, Lewis RW. The male reproductive tract and its fluids. En Dukelow WR, Erwin J, (Eds.) Reproduction and Development in Comparative Primate Biology, New York: Liss; 1986. p.108-109.
Kikiros CS, Beasley SW, Woodward AA. The response of phimosis to local steroid application. Pediatr Surg Int 1993;8:329-332.
Wiswell TE, Hachey WE. Urinary tract infections and the uncircumcised state: an update. Clin. Pediatr 1993;8:130-134.
Frank JD. Circumcision, meatotomy and meatoplasty. In Spitz L, Coran AG, (Eds.) Rob and Smith Pediatric Surgery. London: Chapman & Hall; 1995. p. 738-742.
Zafar F, Thompson JN, Pati J, Kelly EA, Abel PD. Sutureless circumcision. Br J Surg 1993;80:859.
Gee WF, Ansell JS. Neonatal circumcision: a ten-year overview: with com-parison of Gomco clamp and Plastibell device. Pediatrics 1976;58:824-827.
Kaplan GW. Complications of circumcision. Urol Clin North Am. 1983;10:543-549
Metcalf TJ, Osborn LM, Mariani EM. Circumcision: a study of current practices. Clin Pediatr 1983;22:575-579.
Atilla MK, Dundaroz R, Odabas O, Ozturk H, Akin R, Gokcay E. A nonsurgical approach to the treatment of phimosis: local nonsteroidal anti-inflamatory ointment application. J Urol 1997;158:196.197.
Yanagisawa N, Baba K, Yamagoe M, Iwamoto T. Conservative treatment of childhood phimosis with topical conjugated equine estrogen ointment. Int J Urol 2000;7:1-3.
Jorgensen ET, Svensson A. The treatment of phimosis in boys, with a potent topical steroid (clobetasol propionate 0.05%) cream. Acta Derm Venereol 1993; 73:55-56.
Weiss GN. Prophylactic neonatal surgery and infectious diseases. Pediatr Infect Dis J 1997;16:727-734.
Orsola A, Caffaratti J, Garat JM. Conservative treatment of phimosis in children using a topical steroid. Urology 2000;56(2):307-310.
Dewan PA, Tieu HC, Chieng BS. Phimosis: is circumcision necessary? J Paediatr Child Health 1996;32:285-289.
Kayaba H, Tamura H, Kitajima S, Fujiwara Y, Kato T, Kato T. Analysis of shape and retractilibility of the prepuce in 603 Japanese boys. J Urol 1996;156:1813-1815
Kragballe K. Topical corticosteroids: mechanism of action. Acta Derm Venereol 1989;69:7-10.
Haynes RC. Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs: inhibitors of the synthesis and actions of adrenocortical hormone. In Gilman AG, Rall TW, Nies AS, Taylor P. editores .Goodman and Gilman´s The Pharmacological basis of therapeutics. New York 1992; Mc Graw Hill. p. 1443.
Ponec M, De Kloet ER, Kempenaar JA. Corticoids and human skin fibroblasts: intracellular specific binding in relation to growth inhibition. J Invest Dermatol 1980; 75: 293-296.
Golubovic Z, Milanovic D, Vukadinovic V, Rakic I, Perovic S. The conservative treatment of phimosis in boys. Br J Urol 1996; 78: 786-788.
Wright JE. The treatment of childhood phimosis with topical steroid. Aus N Z J Surg 1994; 64: 327-328.